Skip to Content

'
Steven J. Frank, MD

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Adjunct Associate Professor, Department of Radiation Oncology, Division of Diagnostic Imaging, Baylor College of Medicine, Houston, TX
Adjunct Associate Professor, Department of Radiation Oncology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd
Unit Number: 97
Houston, TX 77030
Room Number: B2.4839

Education & Training

Degree-Granting Education

2000 Emory University School of Medicine, Atlanta, GA, MD, General Science
1995 U.S. Naval Nuclear Propulsion Program, Washington, DC, Nuclear Engineer, Nuclear Engineering
1991 University of Pennsylvania, Philadelphia, PA, BA, History

Postgraduate Training

7/2004-8/2004 Clinical Fellowship, Prostate Brachytherapy, Seattle Prostate Institute, Seattle, WA
7/2001-7/2005 Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, Dr. James D. Cox
7/2000-7/2001 Research Internship, Internal Medicine, Emory University School of Medicine, Atlanta, GA
7/1991-7/1996 Nuclear Engineer, Nuclear Engineering, United States Naval Nuclear Propulsion Program, Washington, DC

Board Certifications

7/2006 American Board of Radiology

Experience/Service

Academic Appointments

Adjunct Assistant Professor, Department of Radiation Oncology, Radiology, Baylor College of Medicine, Houston, TX, 7/2010-6/2012
Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2005-2011

Administrative Appointments/Responsibilities

Medical Director, Proton Therapy Center, The UT MD Anderson Cancer Center Proton Therapy Center, Houston, TX, 12/2013-present
Director of Advanced Technologies, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2012-present
Committee Chair, Radiation Oncology (Faculty) Mentoring Program, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2010-present
Committee Chair, RadOnc 2010, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2009-2010

Other Appointments/Responsibilities

Expert Panel Member, Texas Medical Board, Austin, TX, 2009-present

Consultantships

Reviewer/Consultant, The University of Texas MD Anderson Physician's Network, Houston, TX, 10/2009-present

Military or Other Governmental Service

Lieutenant, U. S. Navy, 5/1991-5/1996

Institutional Committee Activities

Ambassador, Physician Relations Faculty Ambassador Program, 6/2013-present
Co-leader, The Center for Radiation Oncology Research Technology Working Group, 1/2013-present
Committee Member, Clinical Safety and Effectiveness (CS&E), 3/2012-present
Co-leader, Research Funding Review Panel, Division of Radiation Oncology, 2012-present
Committee Member, Proton Therapy Conference, 2011-present
Committee Member, Institutional Research Grants - Clinical Study Section, 2011-present
Committee Member, Clinical and Research Informatics, 3/2010-present
Committee Chair, Radiation Oncology (Faculty) Mentoring Program, 2010-present
Committee Member, MD Anderson Physicians Network QA Committee - Head and Neck and Prostate Brachytherapy, 3/2009-present
Board Member, Scientific Publications Advisory Board, 2008-present
Committee Chair, MD Anderson Institutional Grand Rounds, 2008

Honors and Awards

2012-present Head of American Brachytherapy Society Resident Scholarship Program at The University of Texas M. D. Anderson Cancer Center, American Brachytherapy Society
2009-present Best Doctors in America
2008-2012 2008 Young Investigator Award, Prostate Cancer Foundation
2005 3rd International IMRT Treatment Planning Conference Travel Award
2004 American College of Radiology Council Steering Committee
2004 ASTRO Radiation Physics Committee
2004 Seattle Prostate Institute Brachytherapy Fellowship
2003-2005 Association of Residents in Radiation Oncology Executive Board
2003-2005 Residency Review Committee (RRC) for Radiation Oncology
2003 Texas Radiological Society Outstanding Resident Presentation Award
2002 Berlex Oncology Foundation Award
2002 Fletcher Society Resident Research Award
2002 RSNA Research Trainee Award

Professional Memberships

American Board of Radiology, Tucson, AZ
Radiation Oncology Board Certification Committee Member, Head and Neck, 2012-present
Radiation Oncology Board of Certification Exam Writer, 2008-2011
American Brachytherapy Society, Reston, VA
Member, Board of Directors, 2012-2015
Member, 2007-present
American College of Radiology, Reston, VA
Member, Prostate Cancer Appropriateness Committee, 2009-present
Member, 2007-present
American Radium Society
Chair, ARS Industry Relations Committee, 2013-2014
Industry Relations/Development Committee, 2011-2013
Scientific Program Committee, 2011-2013
Member, 2007-present
American Society of Clinical Oncology
Member, 2007-present
American Society of Radiation Oncology
CME/MOC Education Committee, 2013-2014
Member, 2007-present
Gilbert H. Fletcher Society
Nomination Committee, 2012-present
Member, 2007-present
North American Skull Base Society, Houston, TX
Member, 2014-present
Radiological Society of North America
Member, 2007-present
Texas Radiological Society, Houston, TX
Member, 2007-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Tanderup K, Viswanathan A, Kirisits C, Frank SJ. Magnetic Resonance Imaging Guided Brachytherapy. Seminars in Radiation Oncology. In Press.
2. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the node-positive neck in the patient with HPV-associated oropharyngeal cancer. Cancer. In Press. PMID: 24898672.
3. Papadimitrakopoulou VA, Frank SJ, Cohen EW, Hirsch FR, Myers JN, Heymach JV, Lin H, Tran HT, Pharm, Chen CR, Jimeno A, Nedzi L, Vasselli JR, Lowe ES, Raben D. Phase I study of vandetanib with radiation therapy with or without cisplatin in locally advanced head and neck squamous cell carcinoma. In Press.
4. Frank SJ. Sector analysis of iodine-125 brachytherapy for prostate cancer: determining if doses lower than 145Gy achieve an undetectable prostate-specific antigen level. In Press.
5. Petereit DG, Frank SJ, Viswanathan AN, Erickson B, Eifel P, Nguyen PL, Wazer DE. Where Have You Gone Brachytherapy?. In Press.
6. Thaker NG, Kudchadker RJ, Swanson DA, Albert JM, Mahmood U, Pugh TJ, Boehling NS, Bruno TL, Prestidge BR, Crook JM, Cox BW, Potters L, Moran BJ, Keyes M, Kuban DA, Frank SJ. Establishing High Quality Prostate Brachytherapy using a Phantom Simulator Training Program. Int J Radiat Oncol Biol Phys 90(3):579-86, 11/2014. e-Pub 8/2014. PMID: 25151539.
7. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer 120(19):3082-8, 10/2014. e-Pub 6/2014. PMCID: PMC4172550.
8. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for Predicting Symptom Severity during Radiation Therapy for Head and Neck Cancer. Otolaryngol Head Neck Surg 151(4):619-26, 10/2014. e-Pub 8/2014. PMCID: PMC4184965.
9. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G, Expert Panel on Radiation Oncology–Prostate. Response to Drs Rogers, Hayes, and Demanes. Brachytherapy 13(5):523-5, Sep-Oct, 9/2014. e-Pub 5/2014. PMID: 24880587.
10. Frank SJ, Cox JD, Gillin M, Mohan R, Garden AS, Rosenthal DI, Gunn GB, Weber RS, Kies MS, Lewin JS, Munsell MF, Palmer MB, Sahoo N, Zhang X, Liu W, Zhu XR. Multifield Optimization Intensity Modulated Proton Therapy for Head and Neck Tumors: A Translation to Practice. Int J Radiat Oncol Biol Phys 89(4):846-53, 7/2014. e-Pub 5/2014. PMCID: PMC4171724.
11. Holliday EB, Frank SJ. Proton Radiation Therapy for Head and Neck Cancer: A Review of the Clinical Experience to Date. Int J Radiat Oncol Biol Phys 89(2):292-302, 6/2014. e-Pub 5/2014. PMID: 24837890.
12. Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, Morrison WH, Phan J, Rosenthal DI, Fuller CD. Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol 111(2):281-8, 5/2014. e-Pub 4/2014. PMCID: PMC4063998.
13. Melhus CS, Mikell JK, Frank SJ, Mourtada F, Rivard MJ. Dosimetric influence of seed spacers and end-weld thickness for permanent prostate brachytherapy. Brachytherapy 13(3):304-10, May-Jun, 5/2014. e-Pub 10/2013. PMID: 24139289.
14. Lim TY, Stafford RJ, Kudchadker RJ, Sankaranarayanapillai M, Ibbott G, Rao A, Martirosyan KS, Frank SJ. MRI characterization of cobalt dichloride-N-acetyl cysteine (C4) contrast agent marker for prostate brachytherapy. Phys Med Biol 59(10):2505-2516, 5/2014. e-Pub 4/2014. PMCID: PMC4090919.
15. Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. Int J Radiat Oncol Biol Phys 88(5):1074-84, 4/2014. PMID: 24661661.
16. Bian SX, Kuban DA, Levy LB, Oh J, Choi S, McGuire SE, Frank SJ, Mahmood U, Nguyen PL, Pugh TJ, Lee AK, Hoffman KE. The Influence of Age and Comorbidity on the Benefit of Adding Androgen Deprivation to Dose-escalated Radiation in Men With Intermediate-risk Prostate Cancer. Am J Clin Oncol. e-Pub 4/2014. PMID: 24732810.
17. Hsu IC, Yamada Y, Assimos DG, D'Amico AV, Davis BJ, Frank SJ, Gottschalk AR, Gustafson GS, McLaughlin PW, Nguyen PL, Rosenthal SA, Taira AV, Vapiwala N, Merrick G. ACR Appropriateness Criteria high-dose-rate brachytherapy for prostate cancer. Brachytherapy 13(1):27-31, Jan-Feb, 1/2014. e-Pub 12/2013. PMID: 24368283.
18. Sniegowski MC, Warneke CL, Morrison WH, Nasser QJ, Frank SJ, Pfeiffer ML, El-Sawy T, Esmaeli B. Correlation of American Joint Committee on Cancer T Category for Eyelid Carcinoma With Outcomes in Patients With Periocular Merkel Cell Carcinoma. Ophthal Plast Reconstr Surg 30(6):480-485, November/December, 1/2014. e-Pub 5/2014. PMID: 24841735.
19. Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U,Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy 13(1):68-74, Jan-Feb, 1/2014. e-Pub 5/2013. PMID: 23669149.
20. Zhu XR, Poenisch F, Li H, Zhang X, Sahoo N, Wu RY, Li X, Lee AK, Chang EL, Choi S, Pugh T, Frank SJ, Gillin MT, Mahajan A, Grosshans DR. A single-field integrated boost treatment planning technique for spot scanning proton therapy. Radiat Oncol 9:202, 2014. e-Pub 9/2014. PMID: 25212571.
21. Cerne JZ, McGuire SE, Grant SR, Munsell MF, Lee AK, Kudchadker RJ, Choi SL, Mahmood U, Hoffman KE, Pugh TJ, Frank SJ, Kuban DA. Factors associated with improved biochemical response to neoadjuvant androgen deprivation therapy before definitive radiation therapy in prostate cancer patients. Prostate Cancer Prostatic Dis 16(4):346-51, 12/2013. e-Pub 8/2013. PMID: 23939133.
22. Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK. Quality of Life and Toxicity From Passively Scattered and Spot-Scanning Proton Beam Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 87(5):946-53, 12/2013. e-Pub 10/2013. PMCID: PMC4086944.
23. El-Sawy T, Frank SJ, Hanna E, Sniegowski M, Lai SY, Nasser QJ, Myers J, Esmaeli B. Multidisciplinary Management of Lacrimal Sac/Nasolacrimal Duct Carcinomas. Ophthal Plast Reconstr Surg 29(6):454-7, Nov-Dec, 11/2013. PMCID: PMC3830646.
24. Bui M, Frank SJ, Nasser QJ, El Sawy T, McLemore MS, Morrison WH, Esmaeli B. Multidisciplinary management of primary adenoid cystic carcinoma of the eyelid with perineural invasion. Ophthal Plast Reconstr Surg 29(6):e143-6, Nov-Dec, 11/2013. e-Pub 2/2013. PMID: 23446295.
25. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-Reported Outcomes Study. Head Neck 35(10):1490-8, 10/2013. e-Pub 11/2012. PMCID: PMC3788079.
26. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, van Vulpen M, Frank SJ. Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer. Brachytherapy 12(5):401-7, Sep-Oct, 9/2013. e-Pub 2/2013. PMID: 23380383.
27. Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer 119(18):3265-71, 9/2013. e-Pub 6/2013. PMID: 23798338.
28. Gunn GB, Frank SJ. Advances in radiation oncology for the management of oropharyngeal tumors. Otolaryngol Clin North Am 46(4):629-43, 8/2013. e-Pub 6/2013. PMID: 23910474.
29. Quan EM, Liu W, Wu R, Li Y, Frank SJ, Zhang X, Zhu XR, Mohan R. Preliminary evaluation of multi-field and single-field optimization for the treatment planning of spot-scanning proton therapy of head and neck cancer. Med Phys 40(8):081709, 8/2013. PMCID: PMC3732307.
30. Gillenwater AM, Frank SJ, Fatani H, El-Naggar AK. Primary intestinal-like adenocarcinoma of major salivary glands: 2 instances of previously undocumented phenotype. Head Neck 35(8):E234-6, 8/2013. e-Pub 10/2012. PMID: 23108630.
31. Cheung JP, Park PC, Court LE, Ronald Zhu X, Kudchadker RJ, Frank SJ, Dong L. A novel dose-based positioning method for CT image-guided proton therapy. Med Phys 40(5):051714, 5/2013. PMCID: PMC3651206.
32. Register SP, Kudchadker RJ, Levy LB, Swanson DA, Pugh TJ, Bruno TL, Frank SJ. An MRI-based dose--reponse analysis of urinary sphincter dose and urinary morbidity after brachytherapy for prostate cancer in a phase II prospective trial. Brachytherapy 12(3):210-6, May-Jun, 5/2013. e-Pub 3/2013. PMCID: PMC3891368.
33. Yang J, Beadle BM, Garden AS, Gunn B, Rosenthal DI, Ang K, Frank SJ, Williamson R, Balter P, Court L, Dong L. Auto-segmentation of low-risk clinical target volume for head and neck radiation therapy. Pract Radiat Oncol, http://www.practicalradonc.org/article/PIIS1879850013001951/abstract. e-Pub 5/2013.
34. Liu W, Frank SJ, Li X, Li Y, Park PC, Dong L, Ronald Zhu X, Mohan R. Effectiveness of robust optimization in intensity-modulated proton therapy planning for head and neck cancers. Med Phys 40(5):051711, 5/2013. PMCID: PMC3651255.
35. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Hoffman KE, McGuire SE, Swanson DA, Kudchadker R, Davis JW. Endorectal magnetic resonance imaging for predicting pathologic T3 disease in Gleason score 7 prostate cancer: Implications for prostate brachytherapy. Brachytherapy 12(3):204-9, May-Jun, 5/2013. e-Pub 6/2012. PMCID: PMC4158734.
36. Boonsirikamchai P, Choi S, Frank SJ, Ma J, Elsayes KM, Kaur H, Choi H. MR Imaging of Prostate Cancer in Radiation Oncology: What Radiologists Need to Know. Radiographics 33(3):741-61, 5/2013. PMID: 23674772.
37. Frank SJ, Johansen MJ, Martirosyan KS, Gagea M, Van Pelt CS, Borne A, Carmazzi Y, Madden T. A biodistribution and toxicity study of cobalt dichloride-n-acetyl cysteine in an implantable MRI marker for prostate cancer treatment. Int J Radiat Oncol Biol Phys 85(4):1024-1030, 3/2013. e-Pub 10/2012. PMCID: PMC3891365.
38. Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era? Int J Radiat Oncol Biol Phys 85(3):693-699, 3/2013. e-Pub 7/2012. PMID: 22836052.
39. Garden AS, Dong L, Morrison WH, Stugis EM, Glisson BS, Frank SJ, Beadle BM, Gunn GB, Schwartz DL, Kies MS, Weber RS, Ang KK, Rosenthal DI. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 85(4):941-947, 3/2013. e-Pub 9/2012. PMID: 22975604.
40. Albert JM, Swanson DA, Pugh TJ, Zhang M, Bruno TL, Kudchadker RJ, Frank SJ. Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy 12(1):30-7, Jan-Feb, 1/2013. e-Pub 6/2012. PMID: 22727474.
41. McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era. Int J Radiat Oncol Biol Phys 85(1):e39-46, 1/2013. e-Pub 10/2012. PMCID: PMC3840533.
42. Garden AS, Kies MS, Morrison WH, Weber RS, Frank SJ, Glisson BS, Gunn GB, Beadle BM, Ang KK, Rosenthal DI, Sturgis EM. Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century. Radiat Oncol 8(1):21, 2013. e-Pub 1/2013. PMCID: PMC3576243.
43. Kandula S, Zhu X, Garden AS, Gillin M, Rosenthal DI, Ang KK, Mohan R, Amin MV, Garcia JA, Wu R, Sahoo N, Frank SJ. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: A treatment planning comparison. Med Dosim 38(4):390-4, 2013. e-Pub 8/2013. PMID: 23916884.
44. Fisher CM, Troncoso P, Swanson DA, Munsell MF, Kuban DA, Lee AK, Yeh SF, Frank SJ. Knife or Needles? A Cohort Analysis of Outcomes after Radical Prostatectomy or Brachytherapy for Men with Low- or Intermediate-Risk Adenocarcinoma of the Prostate. Brachytherapy 11(6):429-34, Nov-Dec, 11/2012. e-Pub 6/2012. PMID: 22727472.
45. Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol 23(9):2346-52, 9/2012. e-Pub 2/2012. PMID: 22357249.
46. Vassiliev ON, Kudchadker RJ, Kuban DA,Frank SJ , Choi S, Nguyen Q, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med 28(3):240-4, 7/2012. e-Pub 8/2011. PMID: 21875820.
47. Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? Eur J Cancer 48(11):1664-71, 7/2012. e-Pub 2/2012. PMID: 22336663.
48. Sharp HJ, Swanson DA, Pugh TJ, Zhang M, Phan J, Kudchadker R, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of rectal complications following brachytherapy. Pract Radiat Oncol. e-Pub 6/2012. PMID: 22727474.
49. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Gunn GB, Kupferman ME, Ang KK, Rosenthal DI. Unilateral Radiotherapy for the Treatment of Tonsil Cancer. Int J Radiat Oncol Biol Phys 83(1):204-9, 5/2012. e-Pub 10/2011. PMID: 22019242.
50. Abdel-Wahab M, Mahmoud O, Merrick G, Hsu IC, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y. ACR Appropriateness Criteria(®) External-Beam Radiation Therapy Treatment Planning for Clinically Localized Prostate Cancer. J Am Coll Radiol 9(4):233-8, 4/2012. PMID: 22469373.
51. Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy. Int J Radiat Oncol Biol Phys 82(5):e765-71, 4/2012. e-Pub 1/2012. PMID: 22300559.
52. Grimm P, Billiet I, Bostwick D, Dicker AP, Frank SJ, Immerzeel J, Keyes M, Kupelian P, Lee WR, Machtens S, Mayadev J, Moran BJ, Merrick G, Millar J, Roach M, Stock R, Shinohara K, Scholz M, Weber E, Zietman A, Zelefsky M, Wong J, Wentworth S, Vera R, Langley S. Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group. BJU Int 109 Suppl 1:22-9, 2/2012. PMID: 22239226.
53. Frank SJ, Levy LB, van Vulpen M, Crook J, Sylvester J, Grimm P, Pugh TJ, Swanson DA. Outcomes after prostate brachytherapy are even better than predicted. Cancer 118(3):839-47, 2/2012. e-Pub 7/2011. PMID: 21751187.
54. Hinnen KA, Monninkhof EM, Battermann JJ, van Roermund JG, Frank SJ, van Vulpen M. Prostate Specific Antigen Bounce Is Related to Overall Survival in Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 82(2):883-8, 2/2012. e-Pub 2/2011. PMID: 21300477.
55. Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J 18(1):1-8, Jan-Feb, 1/2012. PMID: 22290249.
56. Kudchadker RJ, Pugh TJ, Swanson DA, Bruno TL, Bolukbasi Y, Frank SJ. Preoperative treatment planning with intraoperative optimization can achieve consistent high-quality implants in prostate brachytherapy. Med Dosim 37(4):387-90, 2012. e-Pub 5/2012. PMID: 22560295.
57. Moran BJ, Derose P, Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Mohler JL, Rosenthal SA, Rossi CJ, Yamada Y, Merrick GS, Expert Panel on Radiation Oncology-Prostate:. ACR Appropriateness Criteria® Definitive External Beam Irradiation in Stage T1 and T2 Prostate Cancer. Am J Clin Oncol 34(6):636-647, 12/2011. PMID: 22101389.
58. Expert Panel on Radiation Oncology-Prostate, Frank SJ, Arterbery VE, Hsu IC, Abdel-Wahab M, Ciezki JP, Hahn NM, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G. American College of Radiology Appropriateness Criteria Permanent Source Brachytherapy for Prostate Cancer. Brachytherapy 10(5):357-62, Sep-Oct, 9/2011. e-Pub 4/2011. PMID: 21497562.
59. Vassiliev ON, Kudchadker RJ, Swanson DA, Bruno TL, van Vulpen M, Frank SJ. Displacement of periurethral stranded seeds and its dosimetric consequences in prostate brachytherapy. Brachytherapy 10(5):401-8, Sep-Oct, 9/2011. e-Pub 2/2011. PMID: 21306959.
60. Shirvani SM, Kudchadker RJ, Bruno TL, Likhacheva A, Swanson DA, Frank SJ. Impact Of Urinary Catheterization On Dosimetry After Prostate Implant Brachytherapy With Palladium-103 Or Iodine-125. Brachytherapy 10(4):269-74, Jul-Aug, 7/2011. e-Pub 2/2011. PMID: 21296031.
61. Skinner HD, Garden AS, Rosenthal DI, Ang KK, Morrison WH, Esmaeli B, Pinnix CC, Frank SJ. Outcomes of malignant tumors of the lacrimal apparatus: The University of Texas MD Anderson Cancer Center experience. Cancer 117(12):2801-10, 6/2011. e-Pub 1/2011. PMID: 21656758.
62. Kuban DA, Levy LB, Cheung MR, Lee AK, Choi S, Frank S, Pollack A. Long-term Failure Patterns and Survival in a Randomized Dose-Escalation Trial for Prostate Cancer. Who Dies of Disease? Int J Radiat Oncol Biol Phys 79(5):1310-7, 4/2011. e-Pub 5/2010. PMID: 20493642.
63. Rossi CJ, Joe Hsu IC, Abdel-Wahab M, Arterbery VE, Ciezki JP, Frank SJ, Hahn NM, Moran BJ, Rosenthal SA, Merrick G. ACR Appropriateness Criteria® Postradical Prostatectomy Irradiation in Prostate Cancer. Am J Clin Oncol 34(1):92-98, 2/2011. PMID: 21270599.
64. Skinner HD, Garden AS, Rosenthal DI, Ang KK, Morrison WH, Esmaeli B, Pinnix CC, Frank SJ. Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas M. D. Anderson Cancer Center experience. Cancer. e-Pub 1/2011. PMID: 21225861.
65. Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, Ivan D, Esmaeli B. Positive Sentinel Node in Sebaceous Carcinoma of the Eyelid. Ophthal Plast Reconstr Surg 27(1):e4-6, Jan-Feb, 1/2011. e-Pub 10/2010. PMID: 20940661.
66. Sharp HJ, Swanson DA, Patel H, Gorbatiy V, Frenzel JC, Frank SJ. Subacute penile numbness after brachytherapy for prostate cancer. Brachytherapy 10(1):64-7, Jan-Feb, 1/2011. e-Pub 8/2010. PMID: 20685173.
67. Frank SJ, Tailor RC, Kudchadker RJ, Martirosyan KS, Stafford RJ, Elliott AM, Swanson DA, Sing D, Choi J, Mourtada F, Ibbott GS. Anisotropy characterization of I-125 seed with attached encapsulated cobalt chloride complex contrast agent markers for MRI-based prostate brachytherapy. Med Dosim 36(2):200-5, 2011. e-Pub 5/2010. PMID: 20537886.
68. Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ,. Long-term Tumor Control After Brachytherapy for Cancer at the Base of the Prostate. J Contemp Brachytherapy 3(4):183-187, 2011.
69. Skinner HD, Sturgis EM, Klopp AH, Ang KK, Rosenthal DI, Garden AS, Morrison WH, Gunn GB, Frank SJ, Beadle BM. Characteristics and Clinical Outcomes of Patients with Multiple Potentially HPV-Related Malignancies. Int J Radiat Oncol Biol Phys 78(3, Suppl):S441-S442, 11/2010.
70. Frank SJ, Rosenthal DI, Petsuksiri J, Ang KK, Morrison WH, Weber RS, Glisson BS, Chao KS, Schwartz DL, Chronowski GM, El-Naggar AK, Garden AS. Intensity-Modulated Radiotherapy for Cervical Node Squamous Cell Carcinoma Metastases from Unknown Head-and-Neck Primary Site: M. D. Anderson Cancer Center Outcomes and Patterns of Failure. Int J Radiat Oncol Biol Phys 78(4):1005-10, 11/2010. e-Pub 3/2010. PMID: 20207504.
71. Moeller BJ, Rana V, Cannon BA, Williams MD, Sturgis EM, Ginsberg LE, Macapinlac HA, Lee JJ, Ang KK, Chao KS, Chronowski GM, Frank SJ, Morrison WH, Rosenthal DI, Weber RS, Garden AS, Lippman SM, Schwartz DL. Prospective Imaging Assessment of Mortality Risk After Head-and-Neck Radiotherapy. Int J Radiat Oncol Biol Phys 78(3):667-74, 11/2010. e-Pub 2/2010. PMCID: PMC3072063.
72. Roeloffzen EM, Hinnen KA, Battermann JJ, Monninkhof EM, van Roermund JG, van Gellekom MP, Frank SJ, van Vulpen M. The Impact of Acute Urinary Retention After Iodine-125 Prostate Brachytherapy on Health-Related Quality of Life. Int J Radiat Oncol Biol Phys 77(5):1322-8, 8/2010. e-Pub 11/2009. PMID: 19939578.
73. Rosenthal DI, Fuller CD, Barker JL, Mason B, Garcia JA, Lewin JS, Holsinger FC, Stasney CR, Frank SJ, Schwartz DL, Morrison WH, Garden AS, Ang KK. Simple Carotid-Sparing Intensity-Modulated Radiotherapy Technique and Preliminary Experience for T1-2 Glottic Cancer. Int J Radiat Oncol Biol Phys 77(2):455-61, 6/2010. e-Pub 8/2009. PMID: 19679406.
74. Frank SJ, Kudchadker RJ, Kuban DA, De Crevoisier R, Lee AK, Cheung RM, Choi S, Tucker SL, Dong L. A Volumetric Trend Analysis of the Prostate and Seminal Vesicles during a Course of Intensity-Modulated Radiation Therapy. Am J Clin Oncol 33(2):173-5, 4/2010. PMID: 20010077.
75. Hinnen KA, Battermann JJ, van Roermund JG, Moerland MA, Jürgenliemk-Schulz IM, Frank SJ, van Vulpen M. Long-Term Biochemical and Survival Outcome of 921 Patients Treated with I-125 Permanent Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 76(5):1433-8, 4/2010. e-Pub 6/2009. PMID: 19540075.
76. Roeloffzen EM, Lips IM, van Gellekom MP, van Roermund J, Frank SJ, Battermann JJ, van Vulpen M. Health-Related Quality of Life up to Six Years After (125)I Brachytherapy for early-stage Prostate Cancer. Int J Radiat Oncol Biol Phys 76(4):1054-60, 3/2010. e-Pub 1/2010. PMID: 20097486.
77. Anderson JF, Swanson DA, Levy LB, Kuban DA, Lee AK, Kudchadker R, Phan J, Bruno T, Frank SJ. Urinary Side Effects and Complications After Permanent Prostate Brachytherapy: The MD Anderson Cancer Center Experience. Urology 74(3):601-5, 9/2009. e-Pub 7/2009. PMID: 19589580.
78. Peterson S, Polf J, Ciangaru G, Frank SJ, Bues M, Smith A. Variations in Proton Scanned Beam Dose Delivery Due to Uncertainties in Magnetic Beam Steering. Med Phys 38(8):3693-3702, 8/2009. PMID: 19746802.
79. Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late Rectal Complications after prostate brachytherapy for localized prostate cancer: Incidence and Management. Cancer 115(9):1827-1839, 5/2009. PMID: 19248043.
80. Martirosyan KS, Stafford RJ, Elliott AM, and Frank SJ. PMMA/SWCNTs Composites for Prostate Brachytherapy MRI Contrast Agent Markers. Technical Proceedings of the 2009 NSTI Nanotechnology Conference and Expo 2:44-47, 5/2009.
81. Moeller B, Rana V, Cannon B, Williams M, Sturgis E, Ginsberg L, Macapinlac H, Lee J, Ang KK, Chao KSC, Chronowski G, Frank SJ, Morrison W, Rosenthal D, Weber R, Garden A, Lippman S, Schwartz D. Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer. J Clin Oncol 27(15):2509-2515, 3/2009. e-Pub 3/2009. PMID: 19332725.
82. Frank SJ, Levy LB, Kuban DA, Lee AK, Kudchadker RJ, Bruno TL, van Vulpen M, Swanson DA. Prostogram predicted brachytherapy outcomes are not universally accurate: an analysis based on the M. D. Anderson Cancer Center experience with (125)iodine brachytherapy. J Urol 181(4). e-Pub 2/2009. PMID: 19233434.
83. Hsu A, Frank SJ, Ballo MT, Garden AS, Morrison WH, Rosenthal DI, Hatef E, Esmaeli B. Post-operative Adjuvant External-beam Radiation Therapy for Cancers of the Eyelid and Conjunctiva. Ophthal Plast Reconstr Surg 24(6):444-449, Nov-Dec, 11/2008. PMID: 19033839.
84. Kudchadker RJ, Swanson DA, Kuban DA, Lee AK, Bruno TL, Frank SJ. Is a Loose-Seed Nomogram Still Valid for Prostate Brachytherapy in a Stranded-Seed Era? Int J Radiat Oncol Biol Phys 72(2):623-7, 10/2008.
85. McGuire SE, Frank SJ*, Eifel PJ (*corresponding author). Treatment of recurrent vaginal melanoma with external beam radiation therapy and palladium-103 brachytherapy. Brachytherapy 7(4):359-63, Oct-Dec, 10/2008. e-Pub 9/2008. PMID: 18778972.
86. Frank SJ, Dong L, Kudchadker RJ, De Crevoisier R, Lee AK, Cheung R, Choi S, O'Daniel J, Tucker SL, Wang H, Kuban DA. Quantification of prostate and seminal vesicle interfraction variation during IMRT. Int J Radiat Oncol Biol Phys 71(3):813-20, 7/2008. e-Pub 1/2008. PMID: 18207664.
87. Frank SJ, Stafford RJ, Bankson JA, Li C, Swanson DA, Kudchadker RJ, Martirosyan KS. A Novel MRI Marker for Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 71(1):5-8, 5/2008. PMID: 18406882.
88. Petsuksiri J, Frank SJ, Garden AS, Ang KK, Morrison WH, Chao KS, Rosenthal DI, Schwartz DL, Ahamad A, Esmaeli B (*corresponding author). Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer 112(1):111-8, 1/2008. e-Pub 10/2007. PMID: 17963262.
89. Chao KS, Bhide S, Chen H, Asper J, Bush S, Franklin G, Kavadi V, Liengswangwong V, Gordon W, Raben A, Strasser J, Kaproswki C, Frank SJ, Chronowski G, Ahamad A, Malyapa R, Zhang L, Dong L. Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach. Int J Radiat Oncol Biol Phys 68(5):1512-21, 8/2007. PMID: 17674982.
90. Frank SJ, Pisters LL, Davis J, Lee AK, Bassett R, Kuban DA. An assessment of quality of life following radical prostatectomy, high dose external beam radiation therapy and brachytherapy iodine implantation as monotherapies for localized prostate cancer. J Urol 177(6):2151-6, 6/2007. PMID: 17509305.
91. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 105(2):470-4, 5/2007. e-Pub 2/2007. PMID: 17292459.
92. Cheung MR, Tucker SL, Dong L, de Crevoisier R, Lee AK, Frank S, Kudchadker RJ, Thames H, Mohan R, Kuban D. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 67:1059-65, 3/2007. PMID: 17241755.
93. Frank SJ, Grimm PD, Sylvester JE, Merrick GS, Davis BJ, Zietman A, Moran BJ, Beyer DC, Roach M, Clarke DH, Stock RG, Robert Lee W, Michalski JM, Wallner KE, Hurwitz M, Potters L, Kuban DA, Prestidge BR, Vera R, Hathaway S, Blasko JC. Interstitial Implant Alone or in Combination with External Beam Radiation Therapy for Intermediate-Risk Prostate Cancer: A Survey of Practice Patterns in the United States. Brachytherapy 6(1):2-8, Jan-Mar, 1/2007. PMID: 17284379.
94. Patel S, Jagsi R, Wilson J, Frank S, Thakkar VV, Hansen EK. Results of the 2004 Association of Residents in Radiation Oncology (ARRO) Survey. Int J Radiat Oncol Biol Phys 66(4):1199-203, 11/2006. PMID: 16979833.
95. Lee AK, Frank SJ. Update on radiation therapy in prostate cancer. Hematol Oncol Clin North Am 20(4):857-878, 8/2006. PMID: 16861119.
96. Frank SJ, Chao KS, Schwartz DL, Weber RS, Apisarnthanarax S, Macapinlac HA. Technology Insight: PET and PET/CT in head and neck tumor staging and radiation therapy planning. Nat Clin Pract Oncol 2(10):526-533, 10/2005. PMID: 16205772.
97. Frank SJ, Jhingran A, Levenback C, Eifel PJ. Definitive treatment of invasive squamous cell carcinoma of the vagina with radiation therapy. Int J Radiat Oncol Biol Phys 62(1):138-147, 5/2005. PMID: 15850914.
98. Callaghan EB, Padgett AV, Frank SJ. Self-Referral: What Residents Need to Know? J Am Coll Radiol 2(5):452454, 5/2005. PMID: 17411855.
99. Jagsi R, Buck DA, Singh AK, Engleman M, Thakkar V, Frank SJ, Flynn D. Results of the 2003 Association of Residents in Radiation Oncology (ARRO) surveys of residents and chief residents in the United States. Int J Radiat Oncol Biol Phys 61(3):642-648, 3/2005. PMID: 15708241.
100. Frank SJ, McNeese MD, Strom EA, Perkins G, Salehpour M, Schechter N, Buchholz TA. Advances in radiation treatments of breast cancer. Clin Breast Cancer 4(6):401-406, 2/2004. PMID: 15023240.
101. Brooks C, Starkschall G, Famiglietti R, Cox J, Frank SJ, Komaki R, Liao Z, Stevens C, Forster K. Heterogeneous planning for homogeneous protocols. Med Dosim 29(2):80-84, 2004. PMID: 15191752.
102. Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 56(5):1308-1318, 8/2003. PMID: 12873675.
103. Frank SJ, Curley MD, Ryder SJ. A biomedical review of the U. S. Navy submarine escape system. Rep US Nav Submar Med Cent, 5/1997.
104. Ciezki JP, Merrick G, Hsu IJ, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamanda Y,. Locally Advanced (High-Risk) Prostate Cancer. Prostate Cancer and Prostatic Diseases. Submitted.

Invited Articles

1. Holliday EB, Frank SJ. Current applications of proton beam radiation for the treatment of head and neck tumors. OTORINOLARINGOLOGIA 64:1-11, 3/2014. e-Pub 3/2014.
2. Eberhardt SC, Carter S, Casalino DD, Merrick G, Frank SJ, Gottschalk AR, Leyendecker JR, Nguyen PL, Oto A, Porter C, Remer EM, Rosenthal SA. ACR Appropriateness Criteria prostate cancer--pretreatment detection, staging, and surveillance. J Am Coll Radiol 10(2):83-92, 2/2013. PMID: 23374687.
3. Pugh TJ, Frank SJ. Quality Of Life Issues In The Radiotherapeutic Management Of Localized Prostate Cancer. Radiation Medicine Rounds 2(1), 4/2011.

Editorials

1. Frank SJ. Oncology scan--demonstrating technology and measuring outcomes in head and neck cancer. Int J Radiat Oncol Biol Phys 88(4):759-60, 3/2014. PMID: 24606844.
2. Frank SJ, Yang T, Chao KSC. Role of PET-CT Fusion in Head and Neck Cancer. Oncology 2(19):246-249, 2005.
3. Frank SJ, Buchholz TA. Diminished Survival in Patients with Inner Versus Outer Quadrant Breast Cancers. Women's Oncology Review 3:157-158, 2003.
Other Articles
1. Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. MRI-guided brachytherapy. Seminars in Radiation Oncology, http://authors.elsevier.com/offprints/YSRAO50456/60b16fe48e94bb8df45be422b9bf9023. In Press.
2. Thaker, NG, Guzman AB, Feeley TW, Jones TM, Incalcaterra JR, Kolom C, Tatum LS, Walters RS, Cantor S, Rosenthal DI, Garden, AS, Gunn GB, Fuller, CS, Palmer MB, Frank SJ . Defining the Value of Proton Therapy. Oncology Payers, 8/2014.
3. Tanderup K, Viswanathan AN, Kirisits C, Frank SJ. Magnetic Resonance Image Guided Brachytherapy. Semin Radiat Oncol 24(3):181-91, 7/2014. PMCID: PMC4147854.
4. Ciezki JP, Hsu IC, Abdel-Wahab M, Arterbery VE, Frank SJ, Mohler JL, Moran BJ, Rosenthal SA, Rossi CJ, Yamada Y, Merrick G, American College of Radiology Appropriateness Criteria. American College of Radiology Appropriateness Criteria(®) - Locally Advanced (High-risk) Prostate Cancer. Clin Oncol (R Coll Radiol) 24(1):43-51, 2/2012. e-Pub 8/2011. PMID: 21875782.

Abstracts

1. Zhu XR, Gillin M, Li H, Li Y, Lii MF, Taylor MB, Zhang X, Poenisch F, Sahoo N, Frank SJ. Towards an Efficient and Effective Patient Specific QA Program For IMPT. 51st Annual Meeting of Particle Therapy Co-Operative Group (PTCOG51). In Press.
2. Thaker NG, Kucchadker RJ, Frank SJ. A Phantom-Based Simulator Approach to Improving the Quality of Prostate Brachytherapy Training. American Radium Society’s 96th Annual Meeting, 2014.
3. Melhus CS, Mikell JK, Frank SJ, Mourtada F, Rivard MJ. Dosimetric influence of seed spacers and end-weld thickness for permanent prostate brachytherapy. Brachytherapy 13(3), 10/2013.
4. Liu W, Frank SJ, Li X, Li Y, Zhu RX, Mohan R. PTV-based IMPT optimization incorporating planning risk volumes vs robust optimization. Med Phys 40(2):021709, 2/2013. PMCID: PMC3562272.
5. Hutcheson KA, Lewin JS, Garden AS, Rosenthal DI, Weber RS, William Jr WN, Gunn GB, Morrison WH, Fuller CD, Frank SJ. Early experience with IMPT for the treatment of oropharyngeal tumors: Acute toxicities and swallowing-related outcomes, 2013.
6. Frank SJ, Rosenthal DI, Ang K, Sturgis EM, Chambers MS, Gunn GB, Hutcheson KA, Zhu XR, Palmer MB, Garden A. Gastrostomy tubes decrease by over 50% with intensity modulated proton therapy (IMPT) during the treatment of oropharyngeal cancer patients - A case-control study. Proceedings from ASTRO 2013, 2013.
7. Frank SJ, Cox JD, Gillin M, Rosenthal DI, Garden AS, Ang K, Mohan R, Palmer MB, Amin M, Zhu XR. Intensity modulated proton therapy for head-and-neck cancer: the first clinical experience. Int J Radiat Oncol Biol Phys 84(3):S475-76, 11/2012.
8. Pugh TJ, Choi S, Nguyen Q, De Gracia B, Munsell MF, Frank SJ, Kuban DA, Hoffman KE, McGuire SE, Lee AK. Quality of Life and Toxicity Between Passively Scattered and Spot-Scanning Proton Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 84(3):S392-393, 11/2012.
9. Rosenthal DI, Fuller CD, Holsinger F, Morrison W, Weber RS, Ang K, Frank SJ, A.S. Garden. Conditional Survival for Locally Advanced Larynx Cancer. Int J Radiat Oncol Biol Phys 81(2):S516, 10/2011.
10. Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, Frank SJ. Improving Prostate Brachytherapy Quality Assurance with MRI-based Sector Analysis in a Phase II Prospective Trial. Int J Radiat Oncol Biol Phys 81(2):S209, 10/2011.
11. Garden AS, Morrison WH, Stugis EM, Dong L, Glisson BS, Frank SJ, Kies MS, Weber RS, Ang KK, Rosenthal DI. IMRT for Oropharyngeal Carcinoma: Patient Outcomes and Patterns of Failure. Int J Radiat Oncol Biol Phys 81(2):S15-S16, 10/2011.
12. Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh T, McGuire SE, Kuban DA. Is Androgen Deprivation Therapy Necessary in Intermediate Risk Prostate Cancer Patients Treated in the Dose Escalation Era?. Int J Radiat Oncol Biol Phys 81(2):S40-S41, 10/2011.
13. Beadle BM, Garden AS, Morrison WH, Rosenthal DI, Gunn GB, Frank SJ, Hessel AC, Ang KK. Outcomes and Risk Factors in Patients Treated with Surgery and Postoperative Radiation Therapy Alone: A Subset Update of a Randomized Trial. Int J Radiat Oncol Biol Phys 81(2):S104-S105, 10/2011.
14. Pugh TJ, Frank SJ, Achim M, Kuban DA, Lee AK, Choi S, Nguyen Q, Hoffman K, McGuire SE, Swanson DA. Prediction of Extraprostatic Extension in Intermediate Risk Prostate Cancer: The Evolving Role of Endorectal MRI. Int J Radiat Oncol Biol Phys 81(2):S398, 10/2011.
15. Christensen EN, Pugh TJ, Munsell MF, Swanson DA, Kudchadker RJ, Bruno TL, Brown AP, Frank SJ. Sector Analysis of Prostate Brachytherapy Shows That Low Doses can Achieve an Undetectable PSA. Int J Radiat Oncol Biol Phys 81(2):S422, 10/2011.
16. Chronowski GM, Garden AS, Morrison WH, Frank SJ, Schwartz DL, Shah SJ, Beadle BM, Brandon Gunn G, Kupferman ME, Ang KK, Rosenthal DI. Unilateral Radiotherapy for the Treatment of Tonsil Cancer. Int J Radiat Oncol Biol Phys. e-Pub 10/2011. PMID: 22019242.
17. Nguyen Q, Crawford C, Palmer M, Zhu R, Choi S, Pugh T, Frank SJ, Hoffman K, Kuban DA, Lee AK. Utilizing A Multifield Optimization Intensity Modulated Proton Technique (MFO-IMPT) To Deliver A Simultaneous Integrated Boost (SIB) To The Dominant Intraprostatic Lesion For Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 81(2):S876-S877, 10/2011.
18. Poenisch F, Sahoo N, Taylor MB, Grosshans DR, Frank SJ, Lii M, Wu R, Zhang X, Gillin M, Zhu RX. Verification of Multi-field Optimized Proton Pencil Beam Treatment Plans. Int J Radiat Oncol Biol Phys 81(2):S879, 10/2011.
19. Frank SJ, Levy LB, van Vulpen M, Crook J, Sylvester J, Grimm P, Pugh TJ, Swanson DA. Outcomes after prostate brachytherapy are even better than predicted. Cancer. e-Pub 7/2011. PMID: 21751187.
20. Melhus CS, Mourtada F, Mikell JK, Frank SJ, Rivard MJ. Dosimetric Influence of Brachytherapy Seed Spacers. Brachytherapy 10(1, Suppl):S94 - S95 (#PD71), 5/2011.
21. Frank SJ, Munsell MF, Pugh TJ, Kudchadker RJ, Bruno TL, Kuban DA, Lee AK, Choi S, Nguyen QN, Swanson DA. Long-Term Outcomes, Quality of Life, and Patient-Reported Satisfaction Following Prostate Brachytherapy: The M.D. Anderson Cancer Center Experience. Brachytherapy 10(1, Suppl):S16-S17 (#OR2), 5/2011.
22. Rosenthal DI, Gunn GB, Mendoza TR, Garden AS, Beadle BM, Morrison WH, Wang XS, Frank SJ, Weber RS, Ang KK, Cleeland CS. Long-term symptom burden after radiation treatment for oropharynx cancer: A comparison of 3D and IMRT techniques. J Clin Oncol 29(15S):369s (#5539), 5/2011.
23. Gunn GB, Mendoza TR, Garden AS, Wang XS, Morrison WH, Frank SJ, Hanna EY, Lu C, Beadle BM, Ang KK,Cleeland CS, Rosenthal DI. Patient-reported fatigue in head and neck cancer survivors. J Clin Oncol 29(15S):365s (#5523), 5/2011.
24. Pugh TJ, Frank SJ, Kudchadker R, Swanson DA, Davis JW. Prostate MRI in Men With Intermediate-Risk Prostate Cancer: Implications for Prostate Brachytherapy Monotherapy. Brachytherapy 10(1, Suppl):S30 (#OR34), 5/2011.
25. Papadimitrakopoulou V, Heymach J, Frank SJ, Myers J, Lin H, Tran HT, Chen C, Hirsch FR, Langmuir PB, Vasselli JR, Lippman SM, Raben D. Updated clinical and biomarker results from a phase I study of vandetanib with radiation therapy (RT) with or without cisplatin in locally advanced head and neck squamous cell carcinoma (HNSCC). J Clin Oncol 29(15S):362s (#5510), 5/2011.
26. Frank SJ, Johansen MJ, Martirosyan K, Gagea M, Van Pelt CS, Borne A, Carmazzi Y, Madden T. A Toxicokinetic Evaluation Of Intraprostatically Administered Cobalt Dichloride - N - Acetyl Cysteine (CoCI2-NAC) Conjugate In A Rat Model Of Systemic Exposure. Int J Radiat Oncol Biol Phys 81(2):S433 - S434, 2011.
27. Morikawa LK, Kudchadker R, Kanke J, Oyervides M, Frank SJ, Lee AK, Hoffman K, Choi S, Nguyen Q, Kuban D. Endorectal Balloon in Post-operative Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys 78(3, Suppl):S395, 11/2010.
28. Mendoza TR, Gunn GB, Wang XS, Frank SJ, Beadle BM, Shah SH, Lu C, Hanna EY, Cleeland CS, Rosenthal DI. Impact of Symptom Burden on Survival in Patients With Head and Neck Cancer Treated With Definitive Radiation Therapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S470-S471, 11/2010.
29. Kim MM, Hoffman KE, Levy LB, Master P, Frank SJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in Prostate Cancer Outcomes Over Time: A Twenty-Year Analysis. Int J Radiat Oncol Biol Phys 78(3, Suppl):S191-S192, 11/2010.
30. Albert JM, Zhang M, Bruno TL, Kudchadker RJ, Swanson DA, Frank SJ. MRI-Based Treatment Planning for Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S372-S373, 11/2010.
31. Zhang M, Munsell MF, Swanson DA, Kudchadker RJ, Albert JM, Urbauer DL, Duban DA, Bruno TL, Frank SJ. Patients Can Expect Long-Term Satisfaction After Prostate Brachytherapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S367, 11/2010.
32. Kuban DA, Nogueras-Gonzales GM, Hamblin L, Lee AK, Choi S, Frank SJ, Nguyen QN, Hoffman KE, McGuire SE, Munsell MF. Preliminary Report of a Randomized Dose Escalation Trial for Prostate Cancer using Hypofractionation. Int J Radiat Oncol Biol Phys 78(3, Suppl):S58-S59, 11/2010.
33. Frank SJ, Levy LB, van Vulpen M, Crook J, Sylvester J, Grimm P, Swanson DA. Prostate Cancer Outcomes Following Brachytherapy Are Superior To Those Predicted By the Prostogram. Int J Radiat Oncol Biol Phys 78(3, Suppl):S148, 11/2010.
34. Fisher CM, Troncoso P, Swanson DA, Munsell MF, Kuban DA, Lee AK, Choi S, Nguyen QN, Frank SJ. Prostate Cancer-Specific Survival and Time to Recurrence Outcomes for Men Treated With Radical Prostatectomy, Intensity Modulated Radiation Therapy, or Brachytherapy at M.D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 78(3, Suppl):S147-S148, 11/2010.
35. McGuire SE, Levy LB, Settle SH, Choi S, Nguyen Q, Hoffman K, Frank SJ, Lee AK, Kuban D. PSA Response to Neoadjuvant Androgen Suppression Therapy Prior to High Dose Radiotherapy Predicts Survival in Clinically Localized High Risk Prostate Cancer. Int J Radiat Oncol Biol Phys 78(3, Suppl):S124-S125, 11/2010.
36. Nguyen Q, Levy LB, Lee AK, Choi S, Frank SJ, Hoffman K, McGuire S, Kuban DA. Risk Factors Predicting Failure and Prostate Cancer Mortality in High Risk Prostate Cancer Patients Treated with Definitive External Beam Radiation Therapy. Int J Radiat Oncol Biol Phys 78(3, Suppl):S125, 11/2010.
37. Gunn GB, Garcia SM, Beadle BM, Hanna EY, William WN, Garden AS, Morrison WH, Frank SJ, Ang KK, Rosenthal DI. Skin Culture and Treatment Results in Head and Neck Cancer Patients With Severe Radiation Dermatitis and Potential Suprainfection. Int J Radiat Oncol Biol Phys 78(3, Suppl):S175, 11/2010.
38. Frank SJ, Register S, Levy LB, Kudchadker R, Bruno TL, Swanson DA. An MRI Dose Response Analysis for Urinary Morbidity Following Prostate Brachytherapy Monotherapy in a Phase II Prospective Trial. Brachytherapy 9(2, S1):S42, 4/2010.
39. Choi S, Johnson JL, de Crevoisier R, Lee AK, Dong L, Frank SJ, Nguyen Q, Kuban DA. Comparison of Alignment Using Transabdominal Ultrasound Versus Computed Tomography for Prostate Cancer Patients Treated with Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy. Oncology 24(4, S3):53, 4/2010.
40. Fisher CM, Troncoso P, Kuban DA, Munsell MF, Yeh S, Lee AK, Swanson DA, Frank SJ. Do African American and White Men Have Differences in Their Rate of Pathological Upgrading? An MD Anderson Cohort Study of Radical Prostatectomy, Brachytherapy, and External Beam Patients Treated From 2000-2001. Oncology 24(4, S3):50, 4/2010.
41. Ludwig MS, Lev L, Frank SJ, Hoffman K, Lee AK, McGuire SE, Nguyen QN, Choi S, Woodward W, Kuban DA. Influence of Prognostic Factors on Duration of Hormone Therapy and Outcomes. Oncology 24(4, S3):46, 4/2010.
42. Shirvani SM, Kudchadker RJ, Bruno TL, Swanson DA, Frank SJ. Letting the Catheter Out of the Bag: The Effect of Urinary Catheterization on Post-Implant Dosimetry After Prostate Brachytherapy with Palladium-103. Oncology 24(4, S3):49, 4/2010.
43. Sharp HJ, Swanson DA, Zhang M, Phan J, Bruno TL, Kudchadker R, Kuban DA, Lee AK, Choi S, Nguyen Q, Frank SJ. Prostate Brachytherapy Preceded by Screening Colonoscopy Diagnoses Colorectal Cancers in Asymptomatic Patients. Oncology 24(4, S3):46, 4/2010.
44. Frank SJ. Cobalt Chloride Complex Contrast (C4) agent is safe for MRI-based Prostate Brachytherapy: A Toxicokinetic Evaluation of Intraprostatic Administration in a Rat Model. American Radium Society 92nd Annual Meeting, 2010.
45. Frank SJ, Tailor R, Martirosyan K, Stafford J, Swanson D, Sing D, Choi J, Elliot A, Mourtada F, Kudchadker R, Ibbott G. C4 MRI ECAMS have no effect on I see anisotropy and are visibile after radiation exposure. Proceedings from 30th Annual Meeting of the American Brachytherapy Society 8(2), 5/2009.
46. Whaley JT, Levy LB, Swanson DA, Kudchadker RJ, Bruno TL, Frank SJ. Sexual outcomes unaffected by penile bulb dose in prostate brachytherapy. Proceedings from 30th Annual Meeting of the American Brachytherapy Society 8(2), 5/2009.
47. Parker Pa, Latini DM, Ward JF, Pettaway C, Pisters LL, Matin S, Frank SJ, Brown V, Kuban D, Logothetis C, Kim J, Davis JW. Association between uncertainty, anxiety, and quality of life in men with prostate cancer on active surveillance. Society of Behavioral Medicine 37, 4/2009.
48. Morikawa LK, Levy LB, Choi S, Nguyen QN, Cheung MR, Frank SJ, Lee A, Kuban DA. Relationship Between Psa Failure and Death From Prostate Cancer After Radical External Beam Radiation Therapy. Proceedings from ASTRO 2009 Annual Meeting, 2009.
49. Frank SJ, Stafford RJ, Bankson JA, Swanson DA, Kudchadker RJ, Martirosyan KS. A Novel MRI-based Approach to Prostate Brachytherapy. Proceedings from the World Congress of Brachytherapy, 2008.
50. Martirosyan K, Stafford RJ, Bankson J, Frank S. Encapsulated Contrast Agent Marker (ECAM) for MRI Prostate Brachytherapy. Proceedings from The Minerals, Metals and Materials Society 2008 Annual Meeting, 2008.
51. Phan J, Swanson DA, Kuban DA, Lee AK, Cheung R, Choi S, Kudchadker R, Bruno T, Levy LB, and Frank SJ. Long-term rectal complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings from the Radium Society, 2008.
52. Anderson JF, Swanson DA, Kuban DA, Lee AK, Cheung RM, Choi S, Kudchadker T, Bruno T, Levy LB, Frank SJ. Long-term urinary complications following permanent prostate brachytherapy at the University of Texas M.D. Anderson Cancer Center. Proceedings from the Radium Society, 2008.
53. Frank SJ, Fisher C, Levy LB, Kudchadker R, Kuban DA, Lee AK, Cheung RM, Choi S, Bruno TL, Swanson DA. Pre-implant Urinary Symptoms Predict for Worse Urinary Outcomes. Proceedings from ASTRO 2008, 2008.
54. Frank SJ, Kuban DA, Lee AK, Levy LB, Kudchadker R, Bruno T, Swanson DA. Prostate Brachytherapy – The M.D. Anderson Cancer Center Experience. Proceedings from the American Urologic Association (AUA), 2008.
55. Frank SJ, Swanson DA, Kuban DA, Lee AK, Levy LB. Prostogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on the M. D. Anderson Cancer Center experience with I-125 brachytherapy. Proceeding from the World Congress of Brachytherapy, 2008.
56. Vassiliev ON, Kudchadker RJ, Swanson DA, Kuban DA, Bruno TL, Frank SJ. Systematic Evaluation of Periurethral Stranded Seed Migration and its Dosimetric Consequences in Prostate Brachytherapy. Proceedings from ASTRO 2008, 2008.
57. Frank SJ, Petsuksiri J, Ang KK, Morrison WH, Chao KSC, Rosenthal DI, Schwartz DL, Chronowski G, Weber RS, Garden AS. Intensity Modulated Radiation Therapy for Squamous Cell Carcinoma Metastatic to Cervical Lymph Nodes from an Unknown Primary Site; Outcomes and Patterns of Failure. Proceedings of ASTRO 49th Annual Meeting, 2007.
58. Cheung R, Tucker S, de Crevoisier R, Lee A, Frank SJ, Kudchadker R, Thames , Mohan R, Kuban D. Identification of the bladder dose and volume constraints to control late urinary toxicity after external beam radiotherapy for prostate cancer. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
59. Kanke JE, Amin MA, Wong P, Ang KK, Garden AS, Morrison WH, Chao KSC, Rosenthal D, Allen P, Frank SJ. Optimizing Head and Neck Radiation Treatment Planning Using an IMRT Monoisocentric Technique with a Static Low Anterior Neck Field. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
60. Frank SJ, Pisters LL, David J, Lee AK, Cheung R, Swanson D, Bassett RL, Pettaway CA, Kuban DA. Quality of Life after Monotherapy Treatment for Localized Prostate Cancer: Implant (I-125), Radical Prostatectomy, and High Dose External Beam Radiation. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
61. Petsuksiri J, Frank SJ, Garden AS, Ang KK, Morrison WH, Chao KC, Rosenthal DI, Schwartz DL, Ahamad A, Esmaeli B. Radiation Therapy for Squamous Cell Carcinoma of the Eyelid. ASTRO - 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, Philadelphia, PA. 2006.
62. Frank SJ. 45th Annual Scientific Meeting - ASTRO, Salt Lake City, UT, 2003.
63. Frank SJ. The implementation of heterogeneity corrections for lung cancer. Texas Radiological Society (TRS) 90th Annual Scientific Meeting, Woodlands, TX, 2003.
64. Frank SJ. Heterogeneity vs. Homogeneity corrections for early stage NSCLC. RSNA - Radiological Society of North America, Chicago, IL, 89th Annual Scientific Meeting, 2002.
65. Frank SJ. Treatment planning with heterogeneity corrections for stage I/II lung cancer. Fletcher Society Annual Scientific Meeting, Las Vegas, NV, 2002.
66. Frank SJ. Definitive treatment of vaginal cancer with radiation therapy: The MD Anderson Cancer Center (MDACC) Experience. 1970 -2000, 2000.

Book Chapters

1. Mahajan A, Frank SJ. Radiation Therapy for Orbital and Adnexal tumors. In: M.D. Anderson Solid Tumor Series: Opthalmic Oncology. Ed(s) Esmaeli B. Springer: Houston. In Press.
2. Frank SJ, Gunn GB. Radiotherapy- The “Particle-rs” of energy, dose, and delivery method. In: Otolaryngologic Clinics of North America: Oral Cavity and Oropharyngeal Cancer. Elsevier: Philadelphia, PA, 2013.
3. Frank SJ, Ahamad A, Ang KK. Cancer of the Nasal Cavity and Paranasal Sinuses. In: Clinical Radiation Oncology, 761-777, 2012.
4. Frank SJ, Selek U. Proton Beam Radiation Therapy for Head and Neck Malignancies. In: Curr Oncol Rep. 12, 3, 202-7, 2010. ISBN: 20425080.
5. Frank SJ, Garden AS, Ang K. Principals and Techniques of Radiotherapy and Chemotherapy for Nasal Cavity and Paranasal Sinus Tumors. In: Tumors of Nose, Sinus, and Nasopharynx. Thieme, Stuttgart: Germany. Submitted.

Grant & Contract Support

Title: Optimizing Lymphedema Screening and Education for Breast Cancer Survivors
Funding Source: PCORI
Role: Principal Investigator
Duration: 9/1/2015 - 8/31/2018
 
Title: MRI-LINAC Project
Funding Source: ELEKTA
Role: Co-Principal Investigator
Duration: 7/1/2013 - 6/30/2018
 
Title: Magnetic Resonance Imaging Biomarkers of Radiotherapy-Associated Organ at Risk Injury for Patients enrolled on a Randomized Trial of Photon/Proton Radiotherapy for Oropharyngeal Cancer
Funding Source: Center for Radiation Oncology Research
Role: Co-Investigator
Principal Investigator: Clifton D. Fuller
Duration: 7/1/2013 - 6/30/2014
 
Title: Pre-clinical study of active magnetic field biological influence on radiation responses of human solid tumors
Funding Source: ELEKTA
Role: Principal Investigator
Duration: 7/1/2013 - 6/30/2014
 
Title: Optimization of MR workflow sequences for image-registration, bulk density assignment, target delineation, and dose calculation for head and neck
Funding Source: ELEKTA
Role: Co-Principal Investigator
Principal Investigator: Clifton D. Fuller
Duration: 7/1/2013 - 6/30/2014
 
Title: An in vivo plastic scintillation detector for ultrasound-guided seed implantation during low dose-rate prostate brachytherapy
Funding Source: Odyssey Program
Role: Collaborator
Principal Investigator: Francois Therriault-Proulx
Duration: 9/1/2012 - 8/31/2013
 
Title: Fabrication and validation of implantable MRI markers for prostate cancer treatment
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Duration: 9/15/2010 - 8/31/2011
 
Title: Seeds and Markers for MRI-based Treatment
Funding Source: Texas Ignition Fund
Role: Principal Investigator
Duration: 8/1/2009 - 12/31/2010
 
Title: A Novel Nanoparticle Approach to MRI Prostate Brachytherapy
Funding Source: Prostate Cancer Foundation
Role: Principal Investigator
Duration: 9/1/2008 - 8/31/2012
 
Title: An in-vivo evaluation of C4 for prostate brachytherapy
Funding Source: MDACC (TRC)
Role: Principal Investigator
Duration: 9/1/2008 - 8/31/2010
 
Title: An MRI-based approach to prostate brachytherapy
Funding Source: MDACC (TRC)
Role: Principal Investigator
Duration: 9/1/2007 - 8/31/2008
 
Title: Institutional Start-up Funds
Funding Source: UT MD Anderson Cancer Center
Role: Principal Investigator
Duration: 7/1/2005 - 8/31/2008
 
Title: Radiological Physics Center
Funding Source: NIH/NCI
Role: Co-Principal Investigator
Principal Investigator: Followill
Duration: 9/1/1978 - 12/31/2013

Last updated: 10/27/2014